Steve Harr

Director, President & CEO · 2 filings · Latest: Mar 6, 2026

Sana Biotechnology, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
SANA	Steve Harr	Director, President & CEO	Mar 7, 2026	Option Exercise	$0.00	50,000	—	7,968,596	Mar 10 8:16 PM
SANA	Steve Harr	Director, President & CEO	Mar 6, 2026	Option Exercise	$0.00	41,666	—	7,918,596	Mar 10 8:16 PM